'Huge relief' as teen rings cancer-free bell
Dan Evans, 19, from Newark in Nottinghamshire, described his huge relief ringing the "cancer-free bell" at the teenage cancer ...
Stem Cell Factor (SCF) Market: Forecast to Grow at a 11.4% CAGR, Driven by Recombinant Innovations | Valuates Reports
The Global Stem Cell Factor (SCF) Market was valued at USD 12900 Million in 2023 and is anticipated to reach USD Million by ...
Targeted Oncology17h
FDA Grants Orphan Drug Designation to MB-105 for R/R T-Cell Lymphoma
MB-105, a first-in-class CD5-targeted CAR T-cell therapy, received FDA orphan drug designation for relapsed/refractory T-cell ...
The Street Journal15h
A cure for HIV: ‘One of the hardest goals in science’
HIV is "like a time bomb," said James Riley, a microbiologist at University of Pennsylvania, US. Even now — decades after the virus was identified — and with antiretroviral drugs allowing us to ...
Newark Advertiser22h
Newark’s miracle boy Dan Evans marked the end of his cancer battle as he rang the bell at Nottingham City Hospital
An emotional two-year journey reached a heart-warming milestone as Newark’s miracle boy, who defied all the odds to ring his ...
Stem cells used to partially repair damaged hearts
This is especially problematic in cases of blocked blood vessels, which can repeatedly starve large areas of the heart of ...
MUSC Bone and Marrow Transplant Program survival rate exceeds national average
The Medical University of South Carolina reports that the survival rate for patients in their Bone and Marrow Transplant ...
Gene therapy and bone marrow transplant alleviate ultra-rare genetic disease symptoms
In two new papers, researchers from The Jackson Laboratory (JAX) report the successful use of two approaches—gene therapy and ...